Hypoxia correlates with angiogenesis in cervical cancers

International Journal of Clinical Oncology

Volumn 10, Issue 1, 2005, Pages 35-39

  Tanaka, Hayahito ^a   Yasuda, Yoshiko ^b   Musha, Terunaga ^a   Ueda, Koichi ^c   Nakamura, Yukio ^a  

^a KYORIN UNIVERSITY   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Immunohistochemistry; Low ATP content; Squamous cell carcinoma of human uterine cervix; Tumor angiogenesis; VEGF

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIBODY; FACTOR 8 ANTIBODY; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ADULT; ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXEMIA; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE; UTERINE CERVIX CANCER;

ADENOSINE TRIPHOSPHATE; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL HYPOXIA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION, PATHOLOGIC; UTERINE CERVICAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 15044351718     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-004-0450-0     Document Type: Article

References (30)

1. Yasuda Y, Musha T, Tanaka H, et al. (2001) Inhibition of erythropoietin signalling destroys xenografts of ovarian and uterine cancers in nude mice. Br J Cancer 84:836-843
2. Yasuda Y, Fujita Y, Masuda S, et al. (2002) Erythropoietin is involved in growth and angiogenesis in malignant tumours of female reproductive organs. Carcinogenesis 23:1797-1805
3. Semenza GL (1998) Hypoxia-inducible factor 1 and the molecular physiology of oxygen homeostasis. J Lab Clin Med 131:207-214
4. Buun HF, Poyton RO (1996) Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev 76:839-885
5. 2 homeostasis. Curr Opin Genet Dev 8:588-594
6. Maxwell PH, Wiesener MS, Chang GW, et al. (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen dependent proteolysis. Nature 399:271-275
7. 2 homeostasis by hypoxia-inducible factor 1α. Genes Dev 12:149-162
8. Beck I, Ramirez S, Weinmann R, et al. (1991) Enhancer element at the 3′-flanking region controls transcriptional response to hypoxia in the human erythropoietin gene. J Biol Chem 266:15563-15566
9. Pugh CW, O'Rourke JF, Nagao M, et al. (1997) Activation of hypoxia-inducible factor-1: definition of regulatory domains within the α submit. J Biol Chem 272:11205-11214
10. Semenza GL, Nejfelt MK, Chi SM, et al. (1991) Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc Natl Acad Sci USA 88:5680-5684
11. Semenza GL (1996) Transcriptional regulation by hypoxia-inducible factor 1; molecular mechanisms of oxygen homeostasis. Trends Cardiovasc Med 6:151-157
12. Senger DR, Galli SJ, Dvorak AM, et al. (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983-985
13. Roberts WG, Palade GE (1995) Increased microvascular permeability and endothelial fenestration induce vascular endothelial growth factor. J Cell Sci 108:2369-2379
14. Keck PJ, Hauser SD, Krivi G, et al. (1989) Vascular permeability factor, an endothelial mitogen related to PDGF. Science 246:1309-1312
15. Leung DW, Cathianes G, Kuang W-J, et al. (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309
16. Plouet J (1990) Characterization of the receptor to vasculotropin on bovine adrenal cortex-derived capillary endothelial cells. J Biol Chem 265:22071-22074
17. Clauss M, Gerlach M, Gerlach H, et al. (1990) Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cells and monocyte procoagulant activity and promotes monocyte migration. J Exp Med 172:1535-1545
18. 3 integrin, osteopontin and thrombin. Am J Pathol 149:293-305
19. Yoshida A, Anad-Apte B, Zetter BR (1996) Differential endothelial migration and proliferation of basic fibroblast growth factor and vascular endothelial growth factor. Growth Factors 13:57-64
20. Schweiki D, Itin A, Soffer D, et al. (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845
21. Olson TA, Mohanraj D, Carson LF, et al. (1994) Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res 54:276-280
22. Boocock CA, Charnock-Jones DS, Sharkey AM, et al. (1995) Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J Natl Cancer Inst 87:506-516
23. Zhang L, Yang N, Conejo-Garcia JR, et al. (2003) Expression of endocrine gland derived vascular endothelial growth factor in ovarian carcinoma. Clin Cancer Res 9:264-272
24. Guidi AJ, Abu-Jawdch G, Berse B, et al. (1995) Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J Natl Cancer Inst 87:12137-12145
25. Raleigh JA, Calkins-Adams DP, Rinker LH, et al. (1998) Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinoma using pimonidazole as a hypoxic marker. Cancer Res 58:3765-3768
26. West CML, Cooper RA, Lonecaster JA, et al. (2001) Tumor vascularity: a histological measure of angiogenesis and hypoxia. Cancer Res 61:2907-2910
27. Zamboni L, DeMartino C (1967) Buffered picric acidformaldehyde: a new rapid fixation for electron microscopy (abstract). J Cell Biol 35:148
28. Yasuda Y, Nagao M, Okano M, et al. (1993) Localization of erythropoietin and erythropoietin-receptor in postimplantation mouse embryos. Dev Growth Differ 35:711-722
29. Yasuda Y, Masuda S, Chikuma M, et al. (1998) Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis. J Biol Chem 273:25381-25387
30. Lewis JS, Landers RJ, Underwood JCE, et al. (2000) Expression of vascular endothelial growth factor by macrophages is upregulated in poorly vascularized areas of breast carcinomas. J Pathol 192:150-158